Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-12 4:27 pm Unchanged | 2025-06-11 | 13D | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing History |
| 2025-06-04 4:00 pm Purchase | 2025-05-28 | 13G | iTeos Therapeutics, Inc. ITOS | Ridgeback Capital Investments L.P. | 1,442,959 3.800% | 1,442,959 (New Position) | Filing History |
| 2025-05-19 5:46 pm Sale | 2025-05-15 | 13D | iTeos Therapeutics, Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 2,134,806 4.900% | -2,028,470 (-48.72%) | Filing History |
| 2025-05-16 7:22 pm Purchase | 2025-05-15 | 13D | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 10,688,978 27.900% | 4,958,978 (+86.54%) | Filing History |
| 2025-05-15 5:30 pm Purchase | 2025-05-13 | 13D | iTeos Therapeutics, Inc. ITOS | MPM BioVentures 2014, L.P. | 1,803,996 4.700% | 1,803,996 (New Position) | Filing History |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 3,075,000 8.100% | 750,000 (+32.26%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-05-13 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 3,604,976 (+1625.94%) | Filing History |
| 2025-05-14 6:34 pm Purchase | 2025-05-12 | 13D | iTeos Therapeutics, Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 4,163,276 9.900% | 504,230 (+13.78%) | Filing History |
| 2025-05-13 7:10 pm Purchase | 2025-05-13 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 5,730,000 14.900% | 3,073,360 (+115.69%) | Filing History |
| 2025-05-08 7:43 pm Purchase | 2025-05-01 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 2,656,640 6.900% | 1,048,024 (+65.15%) | Filing History |
| 2025-04-23 8:57 pm Sale | 2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 2,179,420 5.700% | -1,703,129 (-43.87%) | Filing History |
| 2025-04-15 5:04 pm Purchase | 2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Portfolio Management LLC | 2,329,827 6.100% | 2,329,827 (New Position) | Filing History |
| 2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 221,716 0.600% | -2,186,084 (-90.79%) | Filing History |
| 2024-11-21 8:27 pm Purchase | 2024-11-14 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 2,325,000 6.400% | 1,065,524 (+84.60%) | Filing History |
| 2024-11-19 09:57 am Unchanged | 2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Asset Management Inc. | 1,020,052 2.800% | 0 (Unchanged) | Filing History |
| 2024-11-18 9:57 pm Purchase | 2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Asset Management Inc. | 1,020,052 2.800% | 1,020,052 (New Position) | Filing History |
| 2024-11-14 6:04 pm Sale | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 1,608,616 4.400% | -336,056 (-17.28%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | 0 (Unchanged) | Filing History |
| 2024-10-21 4:11 pm Sale | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | -379,196 (-8.90%) | Filing History |
| 2024-10-15 9:49 pm Purchase | 2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,020,052 8.100% | 73,137 (+2.48%) | Filing History |